Meridian Bioscience, Inc.

ACTIVE

3471 River Hills Dr, 俄亥俄州汉密尔顿县, 俄亥俄州, United Stateswww.meridianbioscience.comHolding515 employeesEstablished: 1977-01-01

Also known as:

Meridian Bioscience

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1977

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

25.9%

Phase 2

18.5%

Phase 3

14.8%

Phase 1

3.7%

Phase 4

3.7%

Trial Status Distribution

Completed

81.5%

Terminated

14.8%

Unknown

3.7%

Clinical Trials

Trials sponsored by this organization (27)

Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol

Completed

observational

Feb 2023199 participants

Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.

Not Applicable

Unknown

interventional

Feb 20191,200 participants

Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials

Completed

interventional

May 2018124 participants

Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs.

Not Applicable

Completed

interventional

Feb 2018497 participants

Detection of Cytomegalovirus Virus in Neonates

Completed

observational

Aug 20171,615 participants

Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17

Terminated

interventional

Jun 2017199 participants

Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics

Phase 3

Completed

interventional

May 201754 participants

Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains

Not Applicable

Completed

interventional

Feb 20172,461 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

Back to Organizations